Early-Stage Partner in Care Living Alone Plus
NCT06962111
Summary
EPICLA+ (Early-Stage Partners in Care Living Alone Plus) is a research project designed to assist people with early-stage memory loss who live alone in the community by providing early-stage related education and skill-training sessions, held via Zoom, designed to reduce stress, enhance well-being, manage challenges, and plan for the future. Researchers will gather feedback from individuals about their experience to continue to improve programs for early-stage memory loss.
Eligibility
Early-stage inclusion criteria 1. Must be at least 60 years of age 2. Must be able to participate in English or Spanish 3. Must be a US resident 4. Must be able to provide consent verbally and in writing (electronically or via mail) 5. Must exhibit at least 2 of 8 changes caused by thinking and memory problems on the AD8 (a reliable and valid 8-item dementia screening tool). 6. The Early-stage individual must have a diagnosis of early-stage ADRD or have a Mini-Mental State Exam (MMSE) score: 1. between 20-26 for those who have completed high school, or 2. between 17-26\*, for those who have not completed high school, or 3. 27 or higher with a confirmed diagnosis of early-stage dementia or MCI. 7. Able to participate in EPIC-LA workshops via zoom Exclusion Criteria: 8. Inability to participate via telephone or online video conferencing service. 9. The participant expresses feelings of not wanting to participate 10. The participant do not have enough time to attend the training, 11. The participant demonstrates lack of skills with using a computer that precludes participation 12. The participant does not have a stable internet connection to connect to the video platform 13. The participant has difficulty hearing or a visual impairment that precludes participation.
Conditions4
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06962111